홈 › 전립선암 › 워싱턴

워싱턴의 전립선암 임상 시험

전립선암 관련 연구 55개가 워싱턴 내 여러 지역에서 참여자를 모집하고 있습니다.

워싱턴의 도시

공식 연구 텍스트(영어)

Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging

Providence Regional Cancer System-Aberdeen, Aberdeen
PeaceHealth Saint Joseph Medical Center, Bellingham
Providence Regional Cancer System-Centralia, Centralia
외 19개

피험자 모집 중3상

18세 이상 · 남성 · 2026. 11. 13. 업데이트됨 · NCT04423211

Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer

Fred Hutchinson Cancer Center, Seattle

피험자 모집 중1상

18세 이상 · 남성 · 2026. 11. 12. 업데이트됨 · NCT04221542

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

Kadlec Clinic Hematology and Oncology, Kennewick
Valley Medical Center, Renton

피험자 모집 중2상

18세 이상 · 모든 성별 · 2026. 11. 12. 업데이트됨 · NCT03866382

The Vanguard Study: Testing a New Way to Screen for Cancer

Madigan Army Medical Center, Tacoma

피험자 모집 중건강한 지원자 환영

45세 ~ 75세 · 모든 성별 · 2026. 11. 6. 업데이트됨 · NCT06995898

Study of Oral MRT-2359 With Apalutamide in Prostate Cancer

University of Washington Medical Center, Seattle

피험자 모집 중2상

18세 이상 · 남성 · 2026. 11. 5. 업데이트됨 · NCT07745361

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Providence Regional Cancer System-Aberdeen, Aberdeen
PeaceHealth Saint Joseph Medical Center, Bellingham
Providence Regional Cancer System-Centralia, Centralia
외 20개

피험자 모집 중관찰 연구건강한 지원자 환영

40세 ~ 75세 · 모든 성별 · 2026. 11. 4. 업데이트됨 · NCT05334069

Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial

Swedish Cancer Institute-Edmonds, Edmonds
Swedish Medical Center-First Hill, Seattle

피험자 모집 중2상

18세 이상 · 모든 성별 · 2026. 11. 3. 업데이트됨 · NCT06632977

A Study of JNJ-87189401 Combined With JNJ-78278343 for Advanced Prostate Cancer

Swedish Medical Center, Seattle

피험자 모집 중1상

18세 이상 · 남성 · 2026. 11. 3. 업데이트됨 · NCT06095089

Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial

Swedish Cancer Institute-Edmonds, Edmonds
Swedish Medical Center-First Hill, Seattle

피험자 모집 중3상

18세 이상 · 남성 · 2026. 11. 3. 업데이트됨 · NCT07200830

A Study of JNJ-78278343 in Combination With JNJ-95298177 for Treatment of Prostate Cancer

Fred Hutchinson Cancer Center, Seattle

피험자 모집 중1상

18세 이상 · 남성 · 2026. 11. 3. 업데이트됨 · NCT07082920

Estrogen to Improve Quality of Life for Men With Newly Diagnosed or Recurrent Metastatic Hormone Sensitive Prostate Cancer, EQUIP Trial

Fred Hutch/University of Washington Cancer Consortium, Seattle

피험자 모집 중2상

18세 이상 · 남성 · 2026. 11. 2. 업데이트됨 · NCT07466498

A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)

VA Puget Sound Health Care System ( Site 0054), Seattle
Fred Hutchinson Cancer Center ( Site 0060), Seattle

피험자 모집 중3상

18세 이상 · 남성 · 2026. 10. 30. 업데이트됨 · NCT06925737

Safety, Pharmacokinetics, and Preliminary Efficacy of VIR-5500 (AMX-500) in Prostate Cancer

Fred Hutchinson Cancer Research Center, Seattle

피험자 모집 중1상

18세 이상 · 남성 · 2026. 10. 27. 업데이트됨 · NCT05997615

A Single-Arm Phase II Study of Neoadjuvant Intensified Androgen Deprivation (Leuprolide and Abiraterone Acetate) in Combination With AKT Inhibition (Capivasertib) for High-Risk Localized Prostate Cancer With PTEN Loss

VA Puget Sound Health Care System Seattle Division, Seattle, WA, Seattle

피험자 모집 중2상

18세 이상 · 남성 · 2026. 10. 26. 업데이트됨 · NCT05593497

Precision-Based Genomics in Prostate Cancer

University of Washington, Seattle

피험자 모집 중관찰 연구

18세 ~ 120세 · 남성 · 2026. 10. 26. 업데이트됨 · NCT04706663

Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer

PeaceHealth Saint Joseph Medical Center, Bellingham
Virginia Mason Medical Center, Seattle
Fred Hutchinson Cancer Center, Seattle
외 2개

피험자 모집 중3상

18세 이상 · 남성 · 2026. 10. 23. 업데이트됨 · NCT05946213

Impact of DNA Repair Pathway Alterations on Sensitivity to Radium-223 in Bone Metastatic Castration-resistant Prostate Cancer

Fred Hutch/University of Washington Cancer Consortium, Seattle

피험자 모집 중관찰 연구

18세 이상 · 남성 · 2026. 10. 22. 업데이트됨 · NCT04489719

A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors

Research Site 105, Spokane

피험자 모집 중1/2상

18세 이상 · 모든 성별 · 2026. 10. 21. 업데이트됨 · NCT05914116

A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)

Spokane Urology ( Site 0035), Spokane

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 10. 20. 업데이트됨 · NCT06136650

A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer

Northwest Medical Specialties, PLLC, Tacoma

피험자 모집 중3상

18세 이상 · 남성 · 2026. 10. 20. 업데이트됨 · NCT07213674

Measuring Circulating Tumor Deoxyribonucleic Acid Tumor Fraction to Guide Early 177Lu-PSMA-617 Treatment Discontinuation in Patients With Metastatic Castration-Resistant Prostate Cancer, DYNAMO Trial

Fred Hutch/University of Washington Cancer Consortium, Seattle

피험자 모집 중2상

18세 이상 · 남성 · 2026. 10. 19. 업데이트됨 · NCT07698535

AZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01)

Research Site, Tacoma

피험자 모집 중3상

18세 이상 · 남성 · 2026. 10. 19. 업데이트됨 · NCT07611110

Saruparib in Combination With Physician's Choice of ARPI in Patients With mHSPC Previously Treated With Docetaxel or 177Lu-PSMA Therapy Without Disease Progression and PSA ≥ 0.2 ng/mL (EvoPAR-PR05)

Research Site, Spokane

피험자 모집 중3상

18세 이상 · 남성 · 2026. 10. 15. 업데이트됨 · NCT07711002

Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC

Swedish Medical Center, Seattle
Northwest Medical Specialties, Tacoma

피험자 모집 중3상

18세 ~ 100세 · 남성 · 2026. 10. 15. 업데이트됨 · NCT06855277

This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.

Northwest Medical Specialties, PLLC, Bonney Lake
Northwest Medical Specialties, PLLC, Federal Way
Northwest Medical Specialties, PLLC, Gig Harbor
외 2개

피험자 모집 중3상

18세 이상 · 남성 · 2026. 10. 14. 업데이트됨 · NCT07028853

Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer

FHCC Overlake, Bellevue
Seattle Cancer Care Alliance at EvergreenHealth, Kirkland
FHCC South Lake Union, Seattle
외 2개

피험자 모집 중3상

18세 이상 · 남성 · 2026. 10. 8. 업데이트됨 · NCT03678025

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

University of Washington, Fred Hutchinson Cancer Center, Seattle

피험자 모집 중1/2상

12세 이상 · 모든 성별 · 2026. 10. 2. 업데이트됨 · NCT04585750

Phase 1 Study of ACE-232 to Treat Patients With Metastatic Castration-Resistant Prostate Cancer

Fred Hutchinson Cancer Research Center, Seattle

피험자 모집 중1상

18세 이상 · 남성 · 2026. 9. 25. 업데이트됨 · NCT06801236

Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy

Fred Hutchinson Cancer Research Center, Seattle

피험자 모집 중2/3상

18세 ~ 100세 · 남성 · 2026. 9. 22. 업데이트됨 · NCT06780670

High Dose Testosterone for ATM, CDK12 or CHEK2 Altered Prostate Cancers

VA Puget Sound Health Care System Seattle Division, Seattle, WA, Seattle

피험자 모집 중2상

18세 이상 · 남성 · 2026. 9. 17. 업데이트됨 · NCT05011383

Carboplatin or Olaparib for BRcA Deficient Prostate Cancer

VA Puget Sound Health Care System Seattle Division, Seattle, WA, Seattle

피험자 모집 중2상

18세 이상 · 남성 · 2026. 9. 17. 업데이트됨 · NCT04038502

PROMISE Registry: A Prostate Cancer Registry of Outcomes and Germline Mutations for Improved Survival and Treatment Effectiveness

University of Washington Medical Center, Seattle

피험자 모집 중관찰 연구

18세 이상 · 남성 · 2026. 9. 15. 업데이트됨 · NCT04995198

The SUGAR Study; SBRT and Relugolix) for Prostate Cancer

University of Washington, Seattle

피험자 모집 중2상

18세 이상 · 남성 · 2026. 9. 14. 업데이트됨 · NCT06111781

Prostate Active Surveillance Study

Veterans Affairs Puget Sound Health Care System, Seattle
University of Washington, Seattle

피험자 모집 중관찰 연구

21세 이상 · 남성 · 2026. 9. 2. 업데이트됨 · NCT00756665

A Study of Talazoparib With or Without Enzalutamide in People With Prostate Cancer Who Have Previously Received Abiraterone Acetate or Darolutamide

Fred Hutchinson Cancer Center, Seattle

피험자 모집 중2상

18세 이상 · 남성 · 2026. 8. 21. 업데이트됨 · NCT06844383

A Study of FG-3246 in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC)

Fred Hutchinson Cancer Center, Seattle
University of Washington Medical Center, Seattle
Northwest Medical Specialties, PLLC - Tacoma, Tacoma

피험자 모집 중2상

18세 이상 · 남성 · 2026. 8. 17. 업데이트됨 · NCT06842498

Genomic Biomarker-Selected Umbrella Neoadjuvant Study for High Risk Localized Prostate Cancer

Fred Hutchinson Cancer Center, Seattle

피험자 모집 중2상

18세 이상 · 남성 · 2026. 8. 14. 업데이트됨 · NCT04812366

Cell Therapy (STEAP1 CART) With Enzalutamide for the Treatment of Patients With Metastatic Castration-Resistant Prostate Cancer

Fred Hutch/University of Washington Cancer Consortium, Seattle

피험자 모집 중1/2상

18세 이상 · 남성 · 2026. 8. 11. 업데이트됨 · NCT06236139

A Study to Assess BMS-986460 in Participants With Metastatic Castration-resistant Prostate Cancer

Fred Hutchinson Cancer Center, Seattle

피험자 모집 중1상

18세 이상 · 남성 · 2026. 8. 10. 업데이트됨 · NCT06067841

Vorinostat and 177Lu-PSMA-617 for the Treatment of PSMA-Low Metastatic Castration-Resistant Prostate Cancer

Fred Hutch/University of Washington Cancer Consortium, Seattle

피험자 모집 중2상

전 연령 · 남성 · 2026. 8. 6. 업데이트됨 · NCT06145633

ClinicalTrials.gov 출처, 2026. 11. 15. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.